argenx to Present at Upcoming Investor Conferences

Rhea-AI Summary

argenx (Euronext & Nasdaq: ARGX), a global immunology company, has announced its participation in several upcoming conferences focused on healthcare and biotechnology. Key events include the KBC Life Sciences & Biotech Virtual Conference on September 7, the Morgan Stanley Global Healthcare Conference on September 10, the BofA Global Healthcare Conference on September 16, and the SVB Leerink CybeRx Series event on September 22. Further details can be found on the Investors section of argenx's website.

September 3, 2021

Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences:

• KBC Life Sciences & Biotech Virtual Conference. Management will participate in investor meetings on Tuesday, September 7, 2021.
• Morgan Stanley Global Healthcare Conference. Fireside chat on Friday, September 10, 2021 at 4:15 p.m. ET.
• BofA Global Healthcare Conference. Fireside chat on Thursday, September 16, 2021 at 4:45 p.m. BST.
• SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event. Management will participate in investor meetings on Wednesday, September 22, 2021.

Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, Japan, and Switzerland. For more information, visit www.argenx.com and follow us on LinkedIn. 

For further information, please contact:

Media:
Kelsey Kirk
kkirk@argenx.com

Joke Comijn (EU)
jcomijn@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

Michelle Greenblatt
mgreenblatt@argenx.com

FAQ

What conferences will argenx participate in September 2021?

argenx will participate in four conferences: KBC Life Sciences & Biotech Virtual Conference on September 7, Morgan Stanley Global Healthcare Conference on September 10, BofA Global Healthcare Conference on September 16, and SVB Leerink CybeRx Series event on September 22.

When is the fireside chat at the Morgan Stanley Global Healthcare Conference?

The fireside chat at the Morgan Stanley Global Healthcare Conference is scheduled for September 10, 2021, at 4:15 p.m. ET.

Where can I find more information about the upcoming events of argenx?

Additional information regarding argenx's upcoming events can be found in the Investors section of their website at argenx.com.

What is argenx's focus in the healthcare sector?

argenx is focused on improving the lives of people suffering from severe autoimmune diseases and cancer through innovative antibody-based medicines.

What is the stock symbol for argenx?

The stock symbol for argenx is ARGX.